Excelra

Excelra Excelra accelerates drug discovery & development leveraging advanced data science technologies and d

Excelra's data and analytics solutions empower innovation in life sciences across the value chain from discovery to market. The Excelra Edge comes from a seamless amalgamation of proprietary curated data assets, deep domain expertise and data science. The company's multifaceted teams harmonize and analyze large volumes of disparate unstructured data using cutting-edge technologies. We galvanize da

ta-driven decisions to unlock operational efficiencies to accelerate drug discovery and development. Over the past 18 years, Excelra has been the preferred data and analytics partner to over 90 global clients including 15 of the top 20 large Pharma companies.

Read our latest Case Study to discover how Excelra helped a leading animal health company accelerate veterinary research...
07/07/2025

Read our latest Case Study to discover how Excelra helped a leading animal health company accelerate veterinary research by building a scalable microbiome data platform: https://hubs.la/Q03w0tNp0

We integrated over 52,000 curated studies and 1.1 million samples into a centralized PostgreSQL database with an interactive R Shiny dashboard—reducing manual curation by 65% and enabling seamless exploration and cross-study insights.

Discover how standardized microbiome data can transform your animal health research.
Let’s connect.

AnimalHealth

Ready to elevate consulting results with domain-driven data expertise? Read our latest blog: Why consulting firms need s...
04/07/2025

Ready to elevate consulting results with domain-driven data expertise? Read our latest blog: Why consulting firms need strategic scientific informatics partners
🔗 https://hubs.la/Q03vTYsx0

With genome sequencing expected to hit 40 exabytes/year by 2025, clients demand AI-ready insights from genomics, proteomics, and clinical data. Building in-house analytics is costly and complex. Partnering with scientific informatics experts offers scalable, compliant solutions—NGS pipelines, multi-omics integration, biomarker discovery, and domain expertise—enabling faster, deeper insights without heavy investment.

Elevate your consulting impact—read the full blog to gain the strategic edge.

Read our latest Case study to discover how Excelra helps accelerate KRAS inhibitor research by transforming unstructured...
02/07/2025

Read our latest Case study to discover how Excelra helps accelerate KRAS inhibitor research by transforming unstructured patent data into analysis-ready SAR datasets: https://hubs.la/Q03vnx-60

We extracted and curated over 16,000 compounds from 109 patents using a robust 3-step workflow to deliver structured, analysis-ready SAR datasets.

Harness the power of curated SAR data to supercharge your drug discovery pipeline.

01/07/2025

| Celebrating AI Appreciation Month

This July, we’re spotlighting how Excelra is helping biopharma implement AI — accelerating drug discovery, advancing precision medicine, and transforming healthcare.

From curated data to domain-driven analytics, we’re enabling smarter, faster, and more impactful decisions across the life sciences.
📲 Follow us to see how our AI expertise is driving real progress in biopharma — from discovery to delivery.

Read our latest blog "Genomic Alterations Driving the Next Wave of Innovation and Precision Medicines in Oncology" to le...
27/06/2025

Read our latest blog "Genomic Alterations Driving the Next Wave of Innovation and Precision Medicines in Oncology" to learn how FGFR3 alterations drive the next wave of innovation in precision oncology: https://hubs.la/Q03t6J880

Precision oncology is transforming cancer care by targeting druggable genomic alterations like FGFR3 in urothelial carcinoma. FGFR3 mutations—often single, early oncogenic drivers distinct from TP53 alterations—have fueled major breakthroughs. Erdafitinib, the first FDA-approved FGFR inhibitor, shows clear survival gains and tumor response, especially in FGFR3-altered bladder cancer patients

Explore how FGFR3-targeted therapies are revolutionizing bladder cancer treatment.

That’s a Wrap! | Festival of Genomics Boston 2025What an incredible two days filled with inspiring conversations, fresh ...
26/06/2025

That’s a Wrap! | Festival of Genomics Boston 2025
What an incredible two days filled with inspiring conversations, fresh ideas, and meaningful connections!
A big thank you to everyone who stopped by Booth #65 — it was a pleasure meeting you.
But let’s not stop here. If you have questions, want to learn more, or just want to keep the conversation going — we’re all ears. Let’s connect!
📩 Reach us at Marketing@excelra.com

Day 1 Highlights | Festival of Genomics Boston 2025Great energy, insightful conversations, and new connections! Thank yo...
25/06/2025

Day 1 Highlights | Festival of Genomics Boston 2025

Great energy, insightful conversations, and new connections!
Thank you to everyone who stopped by Booth #65 today. If you haven’t yet, come say hi on the final day tomorrow!

Computational Biology - Where expertise meets innovation.https://hubs.la/Q03sB5Nh0                                      ...
23/06/2025

Computational Biology - Where expertise meets innovation.
https://hubs.la/Q03sB5Nh0

Drug discovery is complex—target identification, biomarker discovery, patient stratification, and more. Our CB team blends deep biological insight with advanced analytics to drive smarter, faster decisions.
🔹 Omics data analysis & biomarker discovery
🔹 Knowledge graphs & semantic web solutions
🔹 Custom pipelines & data engineering
🔹 AI-powered modeling & simulations

Accelerate your research with clarity, precision, and speed.
Predict. Analyze. Connect. Customize.

Could your lab achieve faster, more reliable results? Read our latest blog: "Enhancing Lab Efficiency with Revvity Signa...
20/06/2025

Could your lab achieve faster, more reliable results? Read our latest blog: "Enhancing Lab Efficiency with Revvity Signals" To learn how to get optimize your lab workflows
🔗 https://hubs.ly/Q03sz_s20

With deep expertise in implementing and optimizing Revvity solutions, Excelra helps labs maximize their impact, accelerating workflows, improving data quality, and driving scientific outcomes. Revvity Signals (Notebook, VitroVivo & Inventa) simplifies experiment documentation, streamlines in vitro/in vivo study management, enables AI-driven analytics, and ensures regulatory-grade data integrity.

Discover how we transforms lab workflows into a competitive advantage.

Download our latest whitepaper – BioVisualizer™: Enhancing biological data analysis and interpretation🔗 https://hubs.ly/...
18/06/2025

Download our latest whitepaper – BioVisualizer™: Enhancing biological data analysis and interpretation
🔗 https://hubs.ly/Q03sB5-Y0

In modern life‑science labs, massive biological and preclinical datasets from RNA‑seq to proteomics and metabolomics are generated daily. But managing, analyzing, and visualizing this data efficiently remains a major hurdle. BioVisualizer™ addresses this by providing a user-friendly, web-based platform that integrates structure, real-time interpretation, and publication-ready visuals into a single, intuitive interface.

Learn how the platform empowers you to generate faster insights and make more confident, evidence-driven decisions.

16/06/2025

We’re excited to share that Excelra will be speaking alongside Takeda at The Festival of Genomics & Biodata 2025!
🔗 https://hubs.la/Q03s83Jd0

Catch our Group Head, Program Management – Bioinformatics, Jitesh Kannan Pillai, as he takes the stage with Ying-Wooi Wan, Senior Scientist, Computational Biology at Takeda. Join us at the Biodata stage as we explore how curated data assets can answer key drug discovery questions. From handling diverse multi-omics datasets to implementing metadata curation workflows, we'll share how we're driving impact through the real-time use of data assets at Takeda including the landscape of standard of care, knowledge gaps, and indication expansion.

Don’t miss out. See you there!

Meet our experts at The Festival of Genomics & Biodata 2025 on June 24 & 25 at the BCEC, Boston. Click here to schedule ...
13/06/2025

Meet our experts at The Festival of Genomics & Biodata 2025 on June 24 & 25 at the BCEC, Boston. Click here to schedule a meeting: https://hubs.ly/Q03r-5ZD0

Visit us at Booth #65 to discover how our Bioinformatics, Scientific, and Lab Informatics solutions are transforming the future of life sciences. Whether it’s unlocking the power of data, overcoming FAIRification challenges, or integrating complex datasets for actionable insights, our experts will be there to help you.

Together, let’s unlock the true potential of scientific data and shape the future of healthcare.

Address

Uppal

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Telephone

+91 40 6707 3333

Alerts

Be the first to know and let us send you an email when Excelra posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Excelra:

Share